The lipopolysaccharide of Bordetella bronchiseptica acts as a protective shield against antimicrobial peptides

Infection and Immunity

Volumn 66, Issue 12, 1998, Pages 5607-5612

  Banemann, Andreas ^a   Deppisch, Heike ^a   Gross, Roy ^a,b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b Lehrstuhl fur Biotechnologie   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIUM LIPOPOLYSACCHARIDE; CECROPIN; CECROPIN B; MAGAININ DERIVATIVE; MELITTIN; PROTAMINE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GROWTH; BACTERIAL VIRULENCE; BORDETELLA BRONCHISEPTICA; GENE LOCUS; GENE MUTATION; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; TRANSPOSON;

BORDETELLA BRONCHISEPTICA; BORDETELLA PERTUSSIS;

EID: 0031741283     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.12.5607-5612.1998     Document Type: Article

References (53)

1. Allen, A. G., and D. J. Maskell. 1996. The identification, cloning and mutagenesis of a genetic locus required for lipopolysaccharide biosynthesis in Bordetella pertussis. Mol. Microbiol. 19:37-52.
2. Allen, A. G., R. M. Thomas, J. T. Cadisch, and D. J. Maskell. 1998. Molecular and functional analysis of the lipopolysaccharide biosynthesis locus wlb from Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Mol. Microbiol. 29:27-38.
3. Amano, K.-I., K. Fukushi, and M. Watanabe. 1990. Biochemical and immunological comparison of lipopolysaccharides from Bordetella species. J. Gen. Microbiol. 136:481-487.
4. Aspedon, A., and E. A. Groisman. 1996. The antibacterial action of protamine: evidence for disruption of cytoplasmic membrane energization in Salmonella typhimurium. Microbiology 142:3389-3397.
5. Banemann, A., and R. Gross. 1997. Phase variation affects long-term survival of Bordetella bronchiseptica in professional phagocytes. Infect. Immun. 65: 3469-3473.
6. Beier, D., B. Schwarz, T. M. Fuchs, and R. Gross. 1995. In vivo characterization of the unorthodox BvgS two-component sensor protein of Bordetella pertussis. J. Mol. Biol. 248:596-610.
7. Bensch, K. W., M. Raida, H. J. Magert, P. Schulz-Knappe, and W. G. Forssmann. 1995. hBD-1: a novel β-defensin from human plasma. FEBS Lett. 368:331-335.
8. Bordet, J., and O. Gengou. 1909. L'endotoxine coquechuleuse. Ann. Inst. Pasteur (Paris) 23:415-419.
9. Chaby, R., and M. Caroff. 1988. Lipopolysaccharides of Bordetella pertussis endotoxin, p. 247-271. In A. C. Wardlaw and R. Parton (ed.), Pathogenesis and immunity in pertussis. John Wiley, Chichester, United Kingdom.
10. Devereux, J., P. Haeberli, and O. Smithies. 1984. A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res. 12:387-395.
11. Diamond, G., M. Zasloff, H. Eck, M. Brasseur, W. L. Maloy, and C. L. Bevin. 1991. Tracheal antimicrobial peptide, a cysteine-rich peptide from mammalian tracheal mucosa: peptide isolation and cloning of cDNA. Proc. Natl. Acad. Sci. USA 88:3952-3956.
12. Di Fabio, J. L., M. Caroff, D. Karibian, J. C. Richards, and M. B. Perry. 1992. Characterization of the common antigenic lipopolysaccharide O-chains produced by Bordetella bronchiseptica and Bordetella parapertussis. FEMS Microbiol. Lett. 97:275-282.
13. Ewanowich, C. A., A. R. Melton, A. A. Weiss, R. K. Sherburne, and M. S. Peppler. 1989. Invasion of HeLa 229 cells by virulent Bordetella pertussis. Infect. Immun. 57:2698-2704.
14. Falkow, S., R. R. Isberg, and D. A. Portnoy. 1992. The interaction of bacteria with mammalian cells. Annu. Rev. Cell Biol. 8:333-363.
15. Fernandez, R. C., and A. A. Weiss. 1996. Susceptibilities of Bordetella pertussis strains to antimicrobial peptides. Antimicrob. Agents Chemother. 40: 1041-1043.
16. Finn, T. M., and L. A. Stevens. 1995. Tracheal colonization factor: a Bordetella pertussis secreted virulence determinant. Mol. Microbiol. 16:625-634.
17. Goldman, M. J., G. M. Anderson, E. D. Stolzenberg, U. P. Kari, M. Zasloff, and J. M. Wilson. 1997. Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell 88:553-560.
18. Graeff-Wohlleben, H., S. Killat, A. Banemann, N. Guiso, and R. Gross. 1997. Cloning and characterization of a manganese-containing superoxide dismutase from Bordetella pertussis. J. Bacteriol. 179:2194-2201.
19. Groisman, E. A. 1996. Bacterial responses to host-defense peptides. Trends Microbiol. 4:127-128.
20. Gross, R., and R. Rappuoli. 1988. Positive regulation of pertussis toxin expression. Proc. Natl. Acad. Sci. USA 85:3913-3917.
21. Gueirard, P., C. Weber, A. Le Coustumier, and N. Guiso. 1995. Human Bordetella bronchiseptica infection related to contact with infected animals: persistence of bacteria in host. J. Clin. Microbiol. 33:2002-2006.
22. Guzman, C. A., M. Rohde, M. Bock, and K. N. Timmis. 1994. Invasion and intracellular survival of Bordetella bronchiseptica in mouse dendritic cells. Infect. Immun. 62:5528-5537.
23. Harder, J., J. Bartels, E. Christophers, and J. M. Schröder. 1997. A peptide antibiotic from human skin. Nature 387:861.
24. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
25. Le Blay, K., P. Gueirard, N. Guiso, and R. Chaby. 1997. Antigenic polymorphism of the lipopolysaccharides from human and animal isolates of Bordetella bronchiseptica. Microbiology 143:1433-1441.
26. Lee, C. K., A. L. Roberts, T. M. Finn, S. Knapp, and J. J. Mekalanos. 1990. A new assay for invasion of HeLa229 cells by Bordetella pertussis: effect of inhibitors, phenotypic modulation, and genetic alterations. Infect. Immun. 58:2516-2522.
27. Lehrer, R. I., M. Roseman, S. Harwig, R. Jackson, and P. Eisenhauer. 1991. Ultrasensitive assays for endogenous antimicrobial polypeptides. J. Immunol. Methods 137:167-173.
28. Lehrer, R. I., M. E. Selsted, D. Szklarek, and J. Fleischmann. 1983. Antibacterial activity of microbicidal cationic proteins 1 and 2, natural peptide antibiotics of rabbit lung macrophages. Infect. Immun. 42:10-14.
29. Leininger, E., M. Roberts, J. G. Kenimer, I. G. Charles, N. Fairweather, P. Novotny, and M. J. Brennan. 1992. Comparative roles of the Arg-Gly-Asp sequence present in the Bordetella pertussis adhesins pertactin and filamentous hemagglutinin. Infect. Immun. 60:2380-2385.
30. Maloy, W. L., and U. P. Kari. 1995. Structure-activity studies on magainin and other host defense peptides. Biopolymers 37:105-122.
31. McCray, P. B., Jr., and L. Bentley. Human airway epithelia express a β-defensin. Am. J. Respir. Cell. Mol. Biol. 16:343-349.
32. Monack, D., B. Arico, R. Rappuoli, and S. Falkow. 1989. Phase variants of Bordetella bronchiseptica arise by spontaneous deletions in the vir locus. Mol. Microbiol. 3:1719-1728.
33. Nicolas, P., and A. Mor. 1995. Peptides as weapons against microorganisms in the chemical defense system of vertebrates. Annu. Rev. Microbiol. 49:277-304.
34. Parra-Lopes, C., M. T. Baer, and E. A. Groisman. 1993. Molecular genetic analysis of a locus required for resistance to antimicrobial peptides in Salmonella typhimurium. EMBO J. 12:4053-4062.
35. Peppler, M. S. 1984. Two physically and serologically distinct lipopolysaccharide profiles in strains of Bordetella pertussis and their phenotype variants. Infect. Immun. 43:224-232.
36. Rana, F. R., E. A. Macias, C. M. Sultany, M. C. Modzrakowsky, and J. Blazyk. 1991. Interactions between magainin 2 and Salmonella typhimurium outer membranes: effect of lipopolysaccharide structure. Biochemistry 30: 5858-5866.
37. Ray, A., K. Redhead, S. Selkirk, and S. Poole. 1991. Variability in LPS composition, antigenicity and reactogenicity of phase variants of Bordetella pertussis. FEMS Microbiol. Lett. 79:221-218.
38. Relman, D. A., E. Tuomanen, S. Falkow, D. T. Golenbock, K. Saukkonen, and S. D. Wright. 1990. Recognition of a bacterial adhesin by an integrin: macrophage CR3 (αMβ2, CD11b/CD18) binds filamentous hemagglutinin of Bordetella pertussis. Cell 61:1375-1382.
39. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1992. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
40. Savelkoul, P. H. M., B. Kremer, J. G. Kusters, B. A. M. van der Zeijst, and W. Gaastra. 1993. Invasion of HeLa cells by Bordetella bronchiseptica. Microb. Pathog. 14:161-168.
41. Schipper, H., G. Krohne, and R. Gross. 1994. Epithelial cell invasion and survival of Bordetella bronchiseptica. Infect. Immun. 62:3008-3011.
42. Selsted, M. E., D. Szklarek, and R. I. Lehrer. 1984. Purification and antibacterial activity of antimicrobial peptides of rabbit granulocytes. Infect. Immun. 45:150-154.
43. Shafer, W. M., X. Qu, A. J. Waring, and R. I. Lehrer. 1998. Modulation of Neisseria gonorrhoeae susceptibility to vertebrate antibacterial peptides due to a member of the resistance/nodulation/division efflux pump family. Proc. Natl. Acad. Sci. USA 95:1829-1833.
44. Stainer, D. W., and M. J. Scholte. 1970. A simple chemically defined medium for production of phase I Bordetella pertussis. J. Gen. Microbiol. 63:211-220.
45. Stibitz, S., and M. S. Yang. 1991. Subcellular location and immunological detection of proteins encoded by the vir locus of Bordetella pertussis. J. Bacteriol. 173:4288-4296.
46. Tsai, C. M., and C. E. Frasch. 1982. A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Anal. Biochem. 119:115-119.
47. Turcotte, M. L., D. Martin, B. R. Brodeur, and M. S. Peppler. 1997. Tn5-induced lipopolysaccharide mutations in Bordetella pertussis that affect outer membrane function. Microbiology 143:2381-2394.
48. Uhl, M. A., and J. F. Miller. 1996. Integration of multiple domains in a two-component sensor protein: the Bordetella pertussis BvgAS phosphorelay. EMBO J. 15:1028-1036.
49. Weiss, A. A., and S. Falkow. 1984. Genetic analysis of phase change in Bordetella pertussis. Infect. Immun. 43:263-269.
50. Weiss, A. A., and E. L. Hewlett. 1986. Virulence factors of Bordetella pertussis. Annu. Rev. Microbiol. 40:661-686.
51. Weiss, J., S. Beckerdite-Quagliata, and P. Elsbach. 1980. Resistance of gramnegative bacteria to purified bactericidal leukocyte proteins: relation to binding and bacterial lipopolysaccharide structure. J. Clin. Invest. 65:619-628.
52. Woolfrey, F. B., and J. A. Moody. 1991. Human infections associated with Bordetella bronchiseptica. Clin. Microbiol. Rev. 4:234-255.
53. Zhao, C., I. Wang, and R. I. Lehrer. 1996. Widespread expression of β-defensin hBD-1 in human secretory glands and epithelial cells. FEBS Lett. 396:319-322.